Skip to content
Search

Latest Stories

US tech firm Palantir wins NHS Data Platform contract

US tech firm Palantir wins NHS Data Platform contract

The contract award will see investment of up to £330m over the course of seven years

NHS England is set to introduce a new tool from spring next year to improve care for millions of patients, tackle waiting lists and reduce hospital discharge delays.


The new tool, known as the Federated Data Platform, will bring together key information currently held in separate NHS systems such as the number of beds in a hospital, the size of elective waiting lists, staff rosters, the availability of medical supplies and social care places.

The contract to provide the software has been awarded to US data analytics giant Palantir, with support from Accenture, PwC, NECS and Carnall Farrar.

Over the contractual period of seven years, the NHS will be investing up to £330m in the  data platform and associated services.

In the first contract year, investment is expected to be at least £25.6m, NHSE confirmed on Tuesday (21 November).

Announcing the contract, NHS National Director for Transformation Dr Vin Diwakar said: “Better use of data is essential for the NHS to tackle waiting times, join up patient care and make the health service sustainable for the future.

“Patients come to the NHS at some of the most vulnerable points in their lives, and they want to know that our healthcare teams have access to the best possible information when it comes to their treatment and care.

“This new tool provides a safe and secure environment to bring together data, which enables us to develop and deliver more responsive services for patients and will help the health service drive the recovery in elective care.”

Palantir CEO Alex Karp said that their software can integrate complex, sensitive data in a way that “protects security, respects privacy and puts the customer in full control.”

The NHS also ensured that no company involved in the Federated Data Platform can access health and care data without its permission.

“All data within the platform is under the control of the NHS and will only be used for direct care and planning. It will not be used to access data for research purposes and GP data will not feed into the national version of the software platform,” it said.

Every hospital trust and local health system will have their own version of the software, which enables them to connect and share information between them.

North Tees and Hartlepool Trust, where the system was introduced under pilot projects, has been able to reduce long term stays (21 days or more) by 36 per cent despite increased demand, with 7.7 per cent more patients being admitted to the hospital.

NHSE noted that the new Federated Data Platform builds on the success of the current National Data Platform, for which the contract is about to come to an end.

It will be the first use case in the NHS of Privacy Enhancing Technology (NHS-PET), a nationally assured and funded privacy tool to benefit all NHS organisations.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less